Investor alert: law offices of howard g. smith announces investigation of brainstorm cell therapeutics inc. (bcli) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of brainstorm cell therapeutics inc. (“brainstorm cell” or the “company”) (nasdaq: bcli) investors concerning the company's possible violations of federal securities laws. on november 10, 2022, brainstorm cell disclosed that the u.s. food and drug administration (“fda”) had rejected its new biologics license application (“bla”) for its als treatment, nurown. on this news, brainstorm cell's stock.
BCLI Ratings Summary
BCLI Quant Ranking